Intravenous Acetate for Alcohol Withdrawal Syndrome

This trial tests the safety and feasibility of using an intravenous acetate solution (Sodium Acetate) as a new treatment for alcohol withdrawal syndrome in hospitalized patients. Managing alcohol withdrawal can be challenging with current treatments, which often have serious side effects. The study will compare the effects of the acetate solution to a placebo (a harmless inactive treatment) to determine if it can safely assist patients. Individuals currently receiving treatment for alcohol withdrawal in a hospital setting might be suitable candidates for this trial. As a Phase 1, Phase 2 trial, this research aims to understand how the treatment works in people and measure its effectiveness in an initial, smaller group.

Research has shown that intravenous acetate is safe and well-tolerated in people. In studies involving individuals with alcohol use disorders, the treatment proved practical and did not cause major side effects. It positively impacted brain activity without causing serious problems. Although still in the early stages of testing, these results suggest that sodium acetate can be safely administered to patients.¹²³⁴⁵

Unlike the standard treatments for alcohol withdrawal syndrome, which typically involve benzodiazepines, sodium acetate is a novel option that works by providing an alternative energy source for the brain during withdrawal. Researchers are excited about this treatment because it could potentially stabilize the body's metabolic processes more effectively without the sedative effects associated with traditional medications. Additionally, the intravenous delivery of sodium acetate allows for rapid administration and precise control over dosing, which could lead to quicker relief from withdrawal symptoms. This approach might offer a safer and faster alternative to existing therapies, particularly for patients with severe withdrawal symptoms.

This trial will compare the effects of intravenous acetate with a placebo for treating alcohol withdrawal symptoms. Research has shown that intravenous acetate could help alleviate these symptoms. Acetate, a natural substance produced when the body breaks down alcohol, can also serve as an energy source for the brain. When alcohol consumption stops suddenly, brain acetate levels drop, potentially causing stress and cravings. Early studies found that intravenous acetate is safe and can enhance brain function. This suggests it might reduce withdrawal symptoms by balancing brain chemistry.⁶⁷⁸⁹¹⁰